Matching slides 303,780
Current window 232,951-232,980
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all

Component

232,951-232,980 of 303,780

filter-aware
19
Features a stylized 3D rendering of a cell, likely representing CAR-T or similar cellular therapy.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
20
The slide uses a problem-solution mapping framework to explain the therapeutic approach.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
21
The slide uses a biological mechanism diagram, a Kaplan-Meier survival curve, and IHC images to demonstrate the clinical impact of CD58 loss.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
23
The slide uses a funnel diagram to represent the screening process and bar charts to demonstrate specificity across CD19, CD20, and CD22 targets.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
24
Data shows bioluminescent flux over time; CRG-023 consistently reduces tumor burden to baseline.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
25
CARGO Therapeutics | IPO Presentation Deck | 29 slidesCARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
27
CARGO Therapeutics | IPO Presentation Deck | 29 slidesCARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
28
Includes investor logos, financial metrics, and a timeline of clinical milestones.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
29
CARGO Therapeutics | IPO Presentation Deck | 29 slidesCARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank 1 hit
01
Slide 1
CG Oncology | IPO Presentation Deck | 45 slidesCG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank 1 hit
02
CG Oncology | IPO Presentation Deck | 45 slidesCG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank 1 hit
03
This is a standard IPO 'deal terms' slide.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank 1 hit
06
CG Oncology | IPO Presentation Deck | 45 slidesCG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank 1 hit
07
Uses a comparative diagram to illustrate the biological mechanism.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · Solution1 hit
08
The slide uses a circular process diagram overlaid on a cross-section of a bladder to explain the treatment steps.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · Solution1 hit
10
The slide uses a biological process flow to explain the therapeutic mechanism.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · Solution1 hit
11
The slide uses a three-column layout to categorize the problem into prevalence, clinical challenges, and patient profile.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
12
The diagram shows the progression of tumor invasion through the bladder wall layers (Lamina Propria, Inner Muscle, Deep Muscle).CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · Market SizeLoop · Cost Of Inaction1 hit
13
The slide uses a process flow that transitions into a decision tree/matrix based on risk levels.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
14
The slide highlights the regulatory environment as a key driver for development, citing specific FDA definitions and successful approvals.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
15
The slide uses a hierarchical tree structure to map clinical trials to specific patient segments (Intermediate vs High Risk, BCG-naïve/exposed/unresponsive).CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
16
Includes FDA Fast Track and Breakthrough Therapy designations.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
17
BOND-003 study data.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
19
The slide uses a swimmer plot to visualize individual patient response durations, including complete response, recurrence, and reinduction events.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
20
BOND-003 clinical trial safety data.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
21
The slide explicitly notes that these are not head-to-head studies.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
22
The slide uses a process-flow style layout to define the clinical trial parameters.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
23
The slide uses a swimmer plot to visualize patient-level clinical trial data.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
24
The table lists specific medical conditions (Preferred Terms) and their occurrence rates across 35 patients.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
25
The slide uses a detailed comparison table to highlight the competitive positioning of CG Oncology's CORE-001 trial against other industry players.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit